The two antibodies, casirivimab and imdevimab, should be given to people infected with COVID-19 who are at highest risk of hospitalization or who have weak immune systems. Source

JOIN NCOV.LINK NEWSLETTER

And get notified everytime we publish a new Important announcements. We will not email you often, unless there are important things that need to get in touch with you, such as added new tools or new domain names.